The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Alveolar hemorrhage (AH), diffuse AH (DAH)
Publications
Warfarin-Induced Pulmonary Hemorrhage: A Rare and Life-Threatening Complication in the Resource-Limited Setting of Gaza.
Case reports in pulmonology. 2025;2025:8866411
Diffuse Alveolar Hemorrhage Caused by Warfarin after Rifampicin Discontinuation.
Case reports in medicine. 2019;2019:4917856
Diffuse Alveolar Hemorrhage Associated with Warfarin Therapy.
Case reports in medicine. 2015;2015:350532
A life-threatening complication of warfarin therapy in ED: diffuse alveolar hemorrhage.
The American journal of emergency medicine. 2014;32(6):690.e3-4
Successful management of warfarin-exacerbated diffuse alveolar hemorrhage using an extracorporeal membrane oxygenation.
Multidisciplinary respiratory medicine. 2013;8(1):16
Case records of the Massachusetts General Hospital. Case 1-2007. A 40-year-old woman with epistaxis, hematemesis, and altered mental status.
The New England journal of medicine. 2007;356(2):174-82
Diffuse alveolar hemorrhage secondary to superwarfarin ingestion.
Chest. 1992;102(4):1301-2